Financials
- Market Capitalization 556.27 M
- Employee 231
- Founded 2015
- CEO N/A
- Website www.prokidney.com
- Headquarter Cayman Islands
- FIGI BBG0119BQ2Y2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2869 | CABA Cabaletta Bio, Inc. - Common Stock | 3.12 USD | -7.69% | -0.32% | +14.71% | +106.62% | 528.98 M USD | ||
| 2870 | ZURA Zura Bio Limited - Class A Ordinary shares | 5.73 USD | -2.05% | -2.05% | +3.43% | +170.28% | 549.10 M USD | ||
| 2890 | ENTX Entera Bio Ltd. - Ordinary Shares | 3.04 USD | -1.30% | -5.88% | -5.59% | +52.00% | 526.35 M USD | ||
| 2894 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.36 USD | -3.24% | -0.71% | +11.47% | +114.36% | 517.01 M USD |
Frequently asked questions about ProKidney Corp. Class A Ordinary Shares
What is the ProKidney Corp. Class A Ordinary Shares stock price today?
The current price of ProKidney Corp. Class A Ordinary Shares (PROK) is 1.84. Over the past 24 hours, the stock has changed by +1.10%. Follow the PROK chart for real-time price dynamics.
What is the stock ticker of ProKidney Corp. Class A Ordinary Shares?
ProKidney Corp. Class A Ordinary Shares trades under the ticker PROK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ProKidney Corp. Class A Ordinary Shares stock going up?
PROK has changed by +14.29% over the last week, +17.95% over the last month, and -11.54% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of ProKidney Corp. Class A Ordinary Shares?
ProKidney Corp. Class A Ordinary Shares currently has a market capitalization of 556.27 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were ProKidney Corp. Class A Ordinary Shares earnings last quarter?
Last quarter, ProKidney Corp. Class A Ordinary Shares reported earnings of -0.15 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was ProKidney Corp. Class A Ordinary Shares revenue for the last quarter?
ProKidney Corp. Class A Ordinary Shares reported quarterly revenue of 150 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was ProKidney Corp. Class A Ordinary Shares net income for the last quarter?
ProKidney Corp. Class A Ordinary Shares reported net income of -28.42 M for the last quarter. The previous quarter showed -20.04 M, which means net income changed by -41.85%.
How many employees does ProKidney Corp. Class A Ordinary Shares have?
As of the latest available data, ProKidney Corp. Class A Ordinary Shares has 231 employees. Workforce size can provide additional context about the company's scale and operations.
What is ProKidney Corp. Class A Ordinary Shares EBITDA?
ProKidney Corp. Class A Ordinary Shares EBITDA is -46.7 M, and its EBITDA margin is -31.13 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ProKidney Corp. Class A Ordinary Shares stock?
You can buy ProKidney Corp. Class A Ordinary Shares (PROK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ProKidney Corp. Class A Ordinary Shares stock?
Investing in ProKidney Corp. Class A Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PROK chart and related analysis on metatrader.com as part of your research.